LONCAR CHINA BIOPHARMA ETF - DISTRIBUTING - USD |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-8.08% | -27.92% |
Investment objective
The Loncar China BioPharma ETF (the 'Fund') seeks to track the performance, before fees and expenses, of the Loncar China BioPharma Index (the 'Index').
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 47.06 USD | +1.88% | -8.99% | -21.79% | 3.08% | ||
| 20.9 HKD | -0.48% | +6.96% | +2.20% | 2.58% | ||
| 130.9 USD | +1.10% | -5.39% | -27.40% | 2.48% | ||
| 38.3 HKD | +0.79% | +1.59% | -4.96% | 2.24% | ||
| 20.5 HKD | -0.24% | +3.54% | -5.75% | 2.09% | ||
| 12.98 HKD | +1.41% | -0.46% | -56.15% | 2.09% | ||
| 6.05 HKD | +0.83% | +4.13% | -16.67% | 2.02% | ||
More news
In partnership with
ETF Ratings
 |
Description
| US26922A3703 | |
|---|---|
| Total Expense Ratio | 0.79% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | Loncar China BioPharma Index - USD |
Features and characteristics
| Jurisdiction | |
| Fund Structure | |
| Replication Method | |
| Replication Model | |
| Date of creation |
2018-08-13
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 2023-09-28 )
| AuM (EUR) | 4 M€ |
|---|---|
| AuM 1M | 4 M€ |
| AuM 3 months | 4 M€ |
| AuM 6 months | 5 M€ |
| AuM 12 months | 4 M€ |
- Stock Market
- ETF
- CHNA ETF
